Skip to main content
Clinical Trials/ISRCTN73786674
ISRCTN73786674
Active, not recruiting
未知

Exploring the use of digital therapeutics alongside a remote intensive lifestyle programme on inducing weight loss and diabetes remission in patients with type 2 diabetes versus standard of care.

Habitual Health Ltd0 sites100 target enrollmentJanuary 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Remission in patients with type 2 diabetes
Sponsor
Habitual Health Ltd
Enrollment
100
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2023
End Date
July 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Habitual Health Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Able and willing to give consent for the study prior to participation
  • 2\. Be aged 18 \- 75 years, with type 2 diabetes mellitus of duration \<6 years
  • 3\. Have access to a smartphone or a computer
  • 4\. Have a Body Mass Index (BMI) of at least 28 kg/m²
  • 5\. A HbA1c test \>48 mmol/mol (6\.5%) and \=86 mmol/mol (10%), within the previous 12 months

Exclusion Criteria

  • 1\. Are currently using insulin
  • 2\. Weight change of \>5% in the past 3 months
  • 3\. Have a history or are known to be suffering with alcohol/substance abuse
  • 4\. Have cancer or currently under investigation for cancer
  • 5\. Have had a myocardial infarction within the previous 6 months
  • 6\. Have severe or unstable heart failure e.g. NYHA grade IV
  • 7\. Have porphyria
  • 8\. Have learning difficulties
  • 9\. Are currently on treatment with anti\-obesity drugs
  • 10\. Have had bariatric surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials